You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1576 to 1600 of about 5880
Next 25
11/07/2016
Novocure Announces 38 Presentations on Tumor Treating Fields at 21st Annual Scientific Meeting of the Society of Neuro-Oncology
United Healthcare Issues Positive Coverage Decision for Optune
10/25/2016
Fatal Liver and Bone Marrow Toxicity by Combination Treatment of Dichloroacetate and Artesunate in a Glioblastoma Multiforme Patient: Case Report and Review of the Literature.
10/23/2016
The Musella Foundation announced that it has awarded a $25,000 brain tumor research grant to Dr. Robert Prins of UCLA.
10/22/2016
Patient-Tailored Immunotherapy Shows Promise in Treating Brain Cancer
10/20/2016
An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers.
10/09/2016
High response rate in phase I/II paediatric brain cancer trial
Exclusive: Interview With DelMar Pharmaceutical CEO Jeffrey Bacha
Darren Daulton Battling Brain Cancer Through Charitable Foundation
CIK Treatment Extends Progression-free Survival of Glioblastoma Patients by 1.5 Times
Last chance for NY Islanders Home Opener Fundraiser!
10/06/2016
Veteran With Terminal Brain Cancer Explains Why He’s Against Assisted Suicide
10/05/2016
Tocagen Presents Updated Tumor Response Data for its Cancer-Selective Gene Therapy
10/01/2016
Injecting live virus in brain tumors may fight cancer, study suggests
Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma.
Pioneering Studies Apply New Immunologic Insights to Glioblastoma
Effect of Bevacizumab Plus Temozolomide-Radiotherapy for Newly Diagnosed Glioblastoma with Different MGMT Methylation Status: A Meta-Analysis of Clinical Trials.
09/30/2016
Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Glioblastoma Multiforme
09/28/2016
Glioblastoma: Overview of Disease and Treatment.
Efficacy and Safety of Treating Glioblastoma With Tumor-Treating Fields Therapy
The Musella Foundation For Brain Tumor Research and Information, Inc is proud to announce that we partnered with the DIPG Collaborative to award a $100,000 pediatric brain tumor research grant to Dr. Adrian Krainer, of the Cold Spring Harbor Laboratory in NY.
09/26/2016
Orbus Therapeutics Announces Enrollment of First Patient in Phase 3 Trial in Late-Stage Brain Cancer
09/21/2016
The Clinical Implications of Inconsistently Methylated Results from Glioblastoma MGMT Testing by Replicate Methylation-Specific PCR.
09/19/2016
CNS Oncology Publishes Tumor Treating Fields Treatment Planning and Patient Follow-up Guidelines in Glioblastoma
Brain cancer replaces leukemia as deadliest cancer for kids, study shows